These results partly agree with those of Moroney et al. [23] showing a higher number of cases with CTNNB1 exon 3 mutation in microsatellite stable tumours in a case–control descriptive study including grade 1, early-stage EECs. The gene discussed is CTNNB1; the disease is neoplasm.